Form 4 for EVH Evolent Health, Inc.

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001628908-23-000039 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-03-03	2023-03-01+	EVH	Johnson John Paul	CFO	F - Tax	$35.18	-12.7K	200.0K	-6%	-$446.8K
	2023-03-03	2023-03-01	EVH	Johnson John Paul	CFO	A - Grant	$0.00	+20.4K	212.7K	+11%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-03-01	F	D	3,681	$35.26	209,036	D	—	—	(F4) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
2	Common	Class A Common Stock	2023-03-02	F	D	9,020	$35.15	200,016	D	—	—	(F4) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
3	Common	Class A Common Stock	2023-03-01	A	A	20,413	$0.00	212,717	D	—	—	(F1) Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan. (F2) Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.